Intrinsiqs

Is Enovis Corporation overvalued?

Enovis Corporation (ENOV) looks undervalued — trading about 244% below its fair value.

Undervalued
Current price $18.16 Fair value $62.46
Price
$18.16
Fair value
$62.46
Current P/E
5.4
Normal P/E
18.5
Market cap
$1.05B
Dividend yield
0.0%
Return on equity
-68.2%
Sector
Healthcare

See the full interactive analysis →

Fair value compares ENOV's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.MRK Merck & Co., Inc.RHHBY Roche Holding AGUNH UnitedHealth Group Incorporated